Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
…treatment of advanced melanoma in patients who progress on an anti-PD-1 containing regimen. The PDUFA date set by the FDA…
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
…treatment of advanced melanoma in patients who progress on an anti-PD-1 containing regimen. The PDUFA date set by the FDA…
,
How Tennis Star Naomi Osaka is Helping People of Color Protect Their Skin
…10 million readers. Find the campaign in LA Times or read it online: https://www.futureofpersonalhealth.com/campaign/skin-health/ Read the articles AIM contributed to…
,
Conversations About Immunotherapy and Caregiving
In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…
,
Drawing Strength From Music
…Permanente San Francisco, and host of AIM’s podcast, “Beyond the Clinic: Living Well with Melanoma welcomes music therapist and leader of…
,
2022: The State of Sunscreen in the U.S.
…in Melanoma Research, Professor & Chair, Department of Dermatology, Oregon Health & Science University. Over 197,000 cases of melanoma are…
Survivor Spotlight: Erich & Jenn Djordjevic
…heard about the lesions, Jenn’s mind flashed to 2013, when Erich was diagnosed with Stage IIIB melanoma. He had a…
,
AIM Welcomes Ann Garst Taylor as New Director of Community Engagement
By Mara Klecker Ann Garst Taylor, AIM at Melanoma’s new Director of Community Engagement, has nearly 30 years of volunteer…
,
Things Are About To Get Hairy!
…at Melanoma is proud to have been selected as a 2022 benefitting charity. The “rules” are as simple. You abstain…
How’s it Growing?
AIM at Melanoma is honored to have been selected by the Matthew Hill Foundation to be a benefitting charity in…
,
Shop the Black Ribbon Boutique in May
Since 2020, AIM at Melanoma has partnered with Bonfire.com to sell t-shirts that raise awareness of melanoma as well as…
,
Recent Posts
May. 21, 2026
Webinar: Post-ASCO Melanoma Research Update
May. 04, 2026
Melanoma Monday: Every Day. Everywhere.
Apr. 27, 2026
Lilly Pulitzer and AIM at Melanoma Partner for 5th Annual Community Giving Event
Apr. 19, 2026
KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 10, 2026